October 09, 2018
Rose
A highly unusual response to my article on insurance obstacles to obtaining powerful new cholesterol-lowering drugs came from the very top: the leaders of one of the two companies making the drugs.
from Health https://ift.tt/2pKSyfo
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment